van den Elsen PJ - Search Results

1

Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.

Holling TM, Bergevoet MW, Wierda RJ, van Eggermond MC, van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj, van eggermond mc. Ann N Y Acad Sci. 2009 Sep;1173:538-44. doi: 10.1111/j.1749-6632.2009.04660.x. Ann N Y Acad Sci. 2009. PMID: 19758196

2

Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.

Holling TM, van der Stoep N, Quinten E, van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj, van der stoep n. J Immunol. 2002 Jan 15;168(2):763-70. doi: 10.4049/jimmunol.168.2.763. J Immunol. 2002. PMID: 11777970

3

Regulation of MHC class II expression in human T-cell malignancies.

Holling TM, Schooten E, Langerak AW, van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj. Blood. 2004 Feb 15;103(4):1438-44. doi: 10.1182/blood-2003-05-1491. Epub 2003 Oct 16. Blood. 2004. PMID: 14563641 Free article.

4

DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

van den Elsen PJ, Holling TM, van der Stoep N, Boss JM. van den Elsen PJ, et al. Among authors: van der stoep n. Clin Immunol. 2003 Oct;109(1):46-52. doi: 10.1016/s1521-6616(03)00200-6. Clin Immunol. 2003. PMID: 14585275 Review.

5

Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.

Holling TM, Schooten E, van Den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj. Hum Immunol. 2004 Apr;65(4):282-90. doi: 10.1016/j.humimm.2004.01.005. Hum Immunol. 2004. PMID: 15120183 Review.

6

Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region.

Schooten E, Klous P, van den Elsen PJ, Holling TM. Schooten E, et al. Among authors: van den elsen pj. Immunogenetics. 2005 Nov;57(10):795-9. doi: 10.1007/s00251-005-0051-8. Epub 2005 Nov 8. Immunogenetics. 2005. PMID: 16235089

7

Epigenetic silencing of MHC2TA transcription in cancer.

Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj, van eggermond mc. Biochem Pharmacol. 2006 Nov 30;72(11):1570-6. doi: 10.1016/j.bcp.2006.06.034. Epub 2006 Aug 1. Biochem Pharmacol. 2006. PMID: 16879803 Review.

8

A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

Holling TM, Bergevoet MW, Wilson L, Van Eggermond MC, Schooten E, Steenbergen RD, Snijders PJ, Jager MJ, Van den Elsen PJ. Holling TM, et al. Among authors: van den elsen pj, van eggermond mc. J Immunol. 2007 Oct 15;179(8):5317-25. doi: 10.4049/jimmunol.179.8.5317. J Immunol. 2007. PMID: 17911618

9

Transcriptional silencing of RFXAP in MHC class II-deficiency.

van Eggermond MC, Tezcan I, Heemskerk MH, van den Elsen PJ. van Eggermond MC, et al. Among authors: van den elsen pj. Mol Immunol. 2008 May;45(10):2920-8. doi: 10.1016/j.molimm.2008.01.026. Epub 2008 Mar 12. Mol Immunol. 2008. PMID: 18336911

10

Epigenetic control in immune function.

van den Elsen PJ, van Eggermond MC, Wierda RJ. van den Elsen PJ, et al. Among authors: van eggermond mc. Adv Exp Med Biol. 2011;711:36-49. doi: 10.1007/978-1-4419-8216-2_4. Adv Exp Med Biol. 2011. PMID: 21627041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page